Xponance Inc. grew its stake in shares of Avantor, Inc. (NYSE:AVTR – Get Rating) by 1.0% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 69,206 shares of the company’s stock after acquiring an additional 712 shares during the period. Xponance Inc.’s holdings in Avantor were worth […]
Avantor (NYSE:AVTR – Get Rating) and IsoPlexis (NASDAQ:ISO – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership. Profitability This table compares Avantor and IsoPlexis’ net margins, return on equity […]
Equities analysts predict that Avantor, Inc. (NYSE:AVTR – Get Rating) will post sales of $1.99 billion for the current quarter, Zacks Investment Research reports. Eight analysts have made estimates for Avantor’s earnings, with the highest sales estimate coming in at $2.01 billion and the lowest estimate coming in at $1.97 billion. Avantor reported sales of […]
Avantor, Inc. (NYSE:AVTR – Get Rating) EVP Gerard Brophy sold 19,603 shares of the company’s stock in a transaction that occurred on Friday, May 20th. The shares were sold at an average price of $31.27, for a total transaction of $612,985.81. Following the sale, the executive vice president now owns 96,935 shares in the company, […]